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Abstract
In this work, the influence of direct cell-cell contact in co-cultures of mesenchymal stem cells
(MSCs) and chondrocytes for the improved deposition of cartilage-like extracellular matrix
(ECM) within nonwoven fibrous poly(∊ -caprolactone) (PCL) scaffolds was examined. To this
end, chondrocytes and MSCs were either co-cultured in direct contact by mixing on a single PCL
scaffold or via indirect co-culture whereby the two cell types were seeded on separate scaffolds
which were then cultured together in the same system either statically or under media perfusion in
a bioreactor. In static cultures, the chondrocyte scaffold of an indirectly co-cultured group
generated significantly greater amounts of glycosaminoglycan and collagen than the direct co-
culture group initially seeded with the same number of chondrocytes. Furthermore, improved
ECM production was linked to greater cellular proliferation and distribution throughout the
scaffold in static culture. In perfusion cultures, flow had a significant effect on the proliferation of
the chondrocytes. The ECM contents within the chondrocyte containing scaffolds of the indirect
co-culture groups either approximated or surpassed the amounts generated within the direct co-
culture group. Additionally, within bioreactor culture there were indications that chondrocytes had
an influence on the chondrogenesis of MSCs as evidenced by increases in cartilaginous ECM
synthetic capacity. This work demonstrates that it is possible to generate PCL/ECM hybrid
scaffolds for cartilage regeneration by utilizing the factors secreted by two different cell types,
chondrocytes and MSCs, even in the absence of juxtacrine signaling.
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The tissue engineering paradigm focuses on the combination of cells, scaffolds, and signals
with the ultimate goal of regenerating functional tissues. Currently, a large proportion of
efforts are focused on the development of bioactive materials that serve as a scaffold,
providing structural and mechanical support, and also deliver the bioactive signals to direct
cellular differentiation and tissue growth [1-5]. One approach to developing such bioactive
materials is to utilize components of the extracellular matrix (ECM) that comprises a
particular tissue as a signaling component in an implantable scaffold for the purpose of
directing the regeneration of the tissue of interest.
Cartilage, a tissue which is comprised of relatively few cells, is highly dependent on the
ECM for form and function. Furthermore, repair of this tissue in the absence of bioactive
signals oftentimes results in the repair of a defect with fibrocartilage which is inferior in
compressive strength compared to articular cartilage [6, 7]. As such previous efforts have
focused on creating scaffolds composed of processed excised cartilage, scaffolds composed
solely of isolated collagen and/or glycosaminoglycans (GAGs), as well as engineered three-
dimensional scaffolds coated with cartilaginous ECM components [5, 8-13]. ECM coated
polymeric scaffolds garner the benefits of both the natural and synthetic components. The
polymeric scaffold provides the strength and durability to support tissue development while
the ECM coating acts as a bioactive signal providing necessary cues to direct regeneration
by the host's cells upon implantation. Previous work has shown that chondrocytes cultured
on a scaffold under flow perfusion are capable of depositing cartilage-like ECM within the
scaffold that is effective at inducing the chondrogenic differentiation of MSCs [14].
As potential for the isolation of chondrocytes from healthy cartilage is limited and because
chondrocytes often dedifferentiate upon expansion, other culture methods have been
explored to effectively generate cartilage-like ECM in vitro while reducing the number of
chondrocytes needed. One such method is by utilizing co-cultures of chondrocytes and
MSCs to generate similar quantities of cartilage-like ECM as cultures of chondrocytes alone
[15, 16]. Various studies have shown that co-culturing MSCs with chondrocytes leads to
increased chondrogenic gene expression and ECM deposition when cultured both in direct
cell-cell contact or separated by a barrier, such as a Transwell® membrane, or in
conditioned media systems [17-21]. These phenotypic changes are considered to be the
result of signaling via direct cell to cell contacts [17, 18, 21], as well as secreted factors
generated by MSCs and chondrocytes [19, 22]. Many studies confirm the secretion of
cytokines and growth factors from MSCs exhibiting anti-inflammatory effects in addition to
an increase in matrix production by chondrocytes [23-25] while some studies have
elucidated positive chondroinduction of MSCs co-cultured with chondrocytes shown to
produce growth factors, MMPs, and parathyroid hormone related protein [20, 26, 27].
Previous work showed that a 1:1 ratio of chondrocytes to MSCs was capable of producing
similar quantities of cartilage-like ECM as cultures of chondrocytes alone and that the ECM
exhibited a similar chondroinductive effect on MSCs as polymer/ECM scaffolds generated
using cultures of chondrocytes [15, 28].
The objective of this study was to examine the necessity of direct cell-cell contact in co-
cultures of MSCs and chondrocytes for the improved deposition of a cartilage-like ECM
coating, as defined by an increase in GAG and collagen deposition, within nonwoven
fibrous poly(∊ -caprolactone) (PCL) scaffolds. The hypothesis was that matrix production
by chondrocytes co-cultured in direct contact with MSCs would differ in the deposition of
cartilage-like ECM from indirectly co-cultured groups due to a potential combined effect of
juxtacrine and paracrine signaling. This hypothesis was tested by culturing chondrocytes and
MSCs in direct contact by mixing on the same PCL scaffold as well as in indirect co-
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cultures by seeding the two cell types on two separate scaffolds which were then cultured
together in the same system. Utilizing both static and perfused culture conditions separately,
PCL/ECM construct generation was then characterized by quantifying GAG and collagen
contents as well as through imaging the distribution of cells and matrix throughout the
scaffold via histology and scanning electron microscopy.
2. Materials and methods
2.1. Scaffold formation
Non-woven fibrous poly(∊ -caprolactone) (PCL) scaffolds were fabricated by
electrospinning using previously described methods [15]. 18% (w/w) PCL was first
dissolved in a 5:1 (v/v) solution of chloroform: methanol and expelled at a flowrate of 25
mL/hr into an electric field formed by a voltage source with 30 kV applied voltage. The
collector plate was placed at a distance of 36 cm from the 16 G needle. Following
fabrication, scanning electron microscopy (SEM) (FEI Quanta 400 ESEM FEG, FEICo,
Hillsboro, OR) was employed to examine fiber morphology as well as to measure the
average fiber size for each mat generated. This was achieved by taking a total of 45
measurements from 3 different locations on the mat using the manufacturer supplied
software from which the average and standard deviation were calculated. Electrospun mats 1
mm thick with an average fiber diameter of 8.5 μm and a standard deviation of 1.2 μm were
die cut into 3 mm diameter disks and used for the following cellular studies. The average
porosity of the scaffolds was 91% as determined by mercury porosimetry using previously
described methods [29].
2.2. Cell isolation and expansion
For this study, a previously validated xenogeneic co-culture model using rabbit MSCs and
bovine chondrocytes was utilized [16, 30]. Bovine chondrocytes were isolated from the
femoral condyles of 7-10 day old male calves obtained from Research 87 (Research 87,
Boston, MA). Following a previously established protocol [14, 15, 31], the chondrocytes
from four legs were isolated via a 16 hr incubation with 0.2 wt% collagenase type II
(Worthington, Lakewood, NJ) in culture medium then pooled and cryopreserved. Before
seeding scaffolds for both static and perfusion studies, the chondrocytes were first expanded
for 7 days in chondrocyte growth medium consisting of DMEM (Invitrogen, Carlsbad, CA),
10% fetal bovine serum (FBS), 10 mM HEPES buffer (Gibco, Grand Island, NY), 1% non-
essential amino acids (Gibco, Grand Island, NY), 0.28 mM ascorbic acid (Sigma, St Louis,
MO), 0.4 mM L-proline (Sigma, St Louis, MO), and 1% penicillin-streptomycin-fungizone
(Gibco, Grand Island, NY).
All rabbit MSC isolations were approved by the Rice University Institutional Animal Care
and Use Committee and were in compliance NIH Guide for Care and Use of Laboratory
Animals. Rabbit MSCs were isolated from the bone marrow of male New Zealand White
rabbits weighing 0.9-1.2 kg using an established procedure [14, 15, 28, 32]. After
approximately 2 weeks of expansion following isolation, the MSCs from 6 rabbits were
pooled and cryopreserved. Prior to scaffold seeding the MSCs were removed from
cryopreservation and expanded to passage 3 in general growth medium consisting of
DMEM (Invitrogen, Carlsbad, CA), 10% FBS, and 1% penicillin-streptomycin-fungizone
(Gibco, Grand Island, NY).
2.3. Cell seeding and culture
PCL scaffolds (Ø= 3mm) were pressfit into polycarbonate seeding cassettes and ethylene
oxide sterilized for 12 hr. Following sterilization the scaffolds were pre-wet with a
decreasing ethanol gradient (100% - 35%) and then rinsed with sterile PBS. After pre-
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wetting the scaffolds were incubated overnight in general growth medium to facilitate
cellular attachment.
The expanded MSCs and chondrocytes were then trypsinized and five cell seeding solutions
were prepared. The same cell solutions were used to seed scaffolds for groups AC 35 and
iAC 35 as well as MSC 35 and iMSC 35 (Table 1). In this work, iAC and iMSC indicate
indirect co-cultured scaffolds containing chondrocytes and MSCs respectively. Additionally,
dAC:MSC indicates the direct co-culture group with chondrocytes and MSCs seeded
together on the same scaffold (Figure 1a and Table 1). The number following the group
description indicates the initial seeding density. For the iAC 35 and iMSC 35 groups, 35,000
total cells/scaffold were seeded to control for the total cell number seeded on dAC:MSC
scaffolds. Similarly, the seeding density of the iAC 17.5 and iMSC 17.5 groups was
intended to control for the number of chondrocytes or MSCs seeded initially on the
dAC:MSC scaffolds.
For static studies, chondrocyte growth medium was added to the culture wells after a 2 hr
pre-attachment period. After 24 hrs, the seeded scaffolds were removed from the cassettes
and placed in ultra low attachment 24 well plates. Prior to removing the scaffolds from the
cassettes, the culture wells were divided in half with a vertical piece of polypropylene mesh
(Spectrum Labs, Rancho Dominguez, CA) to spatially separate the iAC and iMSC scaffolds
of similar seeding densities while allowing for the transfer of media and soluble factors
throughout the entire culture well. The scaffolds were then cultured in chondrocyte growth
medium for 14 and 21 days on a shaker table to facilitate media mixing with half of the
medium volume changed every 3 days. The experimental groups and culture arrangements
are described further in Figure 1 and Table 1.
Dynamic cultures were performed in a flow perfusion bioreactor according to previous
studies in our laboratory [31, 33]. Briefly, a cassette containing 10 scaffolds of 3 mm in
diameter was placed in each flow perfusion bioreactor unit, together with 50 mL of
chondrocyte growth medium. The chondrocyte containing scaffolds (AC 35, dAC:MSC,
iAC 35, and iAC 17.5) as well as MSC 35 were subject to direct flow perfusion with each
group in a separate bioreactor. Following the 24 hr attachment period, iMSC 35 and iMSC
17.5 scaffolds, 10 each, were added as free scaffolds to the media reservoir above the
corresponding perfused iAC scaffolds within the perfusion cassettes (Figure 1b). For the
bioreactors containing the groups AC 35, MSC 35, and dAC:MSC, 10 blank PCL scaffolds
were included above the perfusion cassette to control for flow aberrations that may be the
result of the free scaffolds. A stainless steel mesh disk was placed atop the perfusion cassette
to prevent the free floating scaffolds from interfering with media flow (Figure 1b). One third
of the media was changed every 3 days. The scaffolds were cultured for 5, 10, and 14 days
under continuous perfusion at a flow rate of 0.01±0.001 mL/min (1.4 mm/min considering
system geometry) through each scaffold.
2.4. Biochemical assays
For both static and perfused studies, at the end of each culture period scaffolds were
removed from the culture medium and rinsed with PBS 2 times. Two scaffolds were then
pooled in 500 μL of proteinase K and incubated for 16 hrs at 56°C to digest the samples
(static, n = 4; perfusion, n = 8) as described previously [14, 15, 29]. To facilitate the removal
of DNA and ECM components from the scaffold, three freeze-thaw-sonicate cycles were
performed.
Scaffold cellularity was determined by quantifying scaffold DNA content using a PicoGreen
DNA assay kit (Molecular Probes, Eugene, OR) described earlier [15, 28, 29]. Using the
PicoGreen kit, the concentration of double stranded DNA within the proteinase K digest was
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quantified by excitation at 490 nm and emission detected at 520 nm. All samples and
standards were run in duplicate.
ECM production was quantified utilizing the 1,9-dimethymethylene blue and
hydroxyproline colorimetric assays measuring GAG and total collagen contents respectively
according to established protocols [14, 29, 34, 35]. For GAG quantification, 25 μL of
digested sample or chondroitin sulfate standard was treated with 205 μL 1,9-
dimethymethylene blue (Sigma, St Louis, MO ) and absorbance was measured at 520 nm
with samples run in duplicate. For the hydroxyproline assay, 100 μL of proteinase K
digested sample was hydrolyzed at 115°C with 100 μL 12M HCl for 4 hr and then
evaporated under nitrogen flow. The hydrolyzed samples were then rehydrated with water
and analyzed in duplicate by incubation with 50 μL chloramine-T (Sigma, St Louis, MO)
and 50 μL p-dimethylaminobenzaldehyde (Sigma, St Louis, MO) at 60°C for 30 min [36].
The absorbance of the samples and hydroxyproline standards were measured at 570 nm.
2.5. Histology
After each static and perfused culture period, samples (n=2) were rinsed twice with PBS and
fixed in 10% buffered formalin at 4°C overnight. The fixed samples were then dehydrated
using an increasing ethanol gradient, stored in 100% ethanol at 4°C overnight, then placed in
HistoPrep freezing media (Fisher, Fair Lawn, NJ) for at least 24 hr. Finally the samples were
embedded in freezing media and 8 μm sections were cryosectioned (CM1850, Leica
Microsystems, Bannockburn, IL) and affixed to glass Superfrost Plus microscope slides
(VWR, Batavia, IL). The sections were then incubated on a slide warmer for 7 days at 45°C.
Picro sirius red staining was utilized to examine the distribution of ECM components within
the scaffold, specifically collagen. Using previously established staining protocols, the
sections were hydrated and then treated with 1 g/L Direct Red 80 (Sigma Aldrich, St Louis,
MO) in saturated aqueous picric acid [15, 28, 34]. After an hour, the sections were clarified
twice with 0.5% acetic acid. Cellular localization was visualized by hydrating the section
then staining with 1 g/L Nuclear Fast Red (Sigma Aldrich, St Louis, MO) in 50 g/L
aluminum sulfate for 5 min then rinsing with water. Following staining, sections were
imaged via light microscopy (Zeiss AxioImager.Z2, Göttingen, Germany) coupled with a
digital camera (Zeiss AxioCamMRc5, Göttingen, Germany) correcting exposure and white
balance using the manufacturer supplied software.
2.6. Scanning electron microscopy
The surface morphology of the scaffolds was imaged using scanning electron microscopy to
examine the progression of ECM and cells on the surface of the scaffold. Scaffolds from
each time point (n = 2) were fixed for 1 hr in 2.5% glutaraldehyde and dried using an
increasing ethanol gradient. Samples were then sputtercoated with 20 nm of gold (Denton
Desk V, Moorestown, NJ) and SEM (FEI Quanta 400 ESEM FEG, FEICo, Hillsboro, OR)
images were obtained.
2.7. Statistical analysis
The results of the biochemical assays are presented as means ± standard deviation. A two-
way ANOVA was utilized to determine significant differences in DNA and ECM contents
of the scaffolds as the result of culture duration and cell population. Tukey's HSD testing
was used to perform multiple comparisons when significance via ANOVA was determined.
For all statistical analyses, significance was defined as p<0.05.
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SEM was utilized to examine the surface morphology of the scaffolds with the progressing
deposition of ECM and proliferation of the cells within the different groups (Figure 2 and
Supplementary Figure 1). For static samples, within 14 days the surfaces of scaffolds
cultured with chondrocytes were mostly covered with ECM and cells (Supplementary Figure
1 (a)-(d)). It took between 14 and 21 days for the deposits of ECM and cells to primarily
obscure the underlying PCL fibers within these static chondrocyte containing groups. For
the static MSC-only scaffolds, only the iMSC 17.5 group displayed prominent evidence of
ECM and cells on the scaffold surface in 14 days (Supplementary Figure 1 (e)-(g)).
However, within 21 days the surfaces of all three static MSC-only scaffolds were mostly
covered with cells and ECM. On the scaffolds cultured in the bioreactor, the surface of the
chondrocyte containing groups were completely covered with cells and ECM in 5 days
except for the iAC 35 group which was covered within 10 days (Figure 2 (a)-(d)). For the
MSC-only scaffolds, all three MSC-only scaffolds were covered with cells and ECM by day
14 (Figure 2 (e)-(g)). Furthermore, as it becomes more difficult to discern the underlying
PCL fibers the surface morphology of the cell and ECM coating becomes more rough in
appearance for both static and bioreactor cultures (Supplementary Figure 1 d21 (a) and (d);
Figure 2 d10 (c) and d14 (a)).
3.2. Histological characterization
Within scaffolds cultured statically, Nuclear Fast Red staining for cell nuclei shows that a
great proportion of the cells were located at the surface of the scaffolds at both time points
(Supplementary Figure 2). However, among all of the static scaffolds the 3 groups seeded
with chondrocytes alone displayed the greatest distribution of cells and matrix within the
scaffold at both time points as indicated by Nuclear Fast Red and Picro Sirius Red staining
respectively (Figure 3 and Supplementary Figure 2 (a)-(c)). Comparing between the
dAC:MSC and iAC groups, there was little difference in cell localization or matrix
distribution at 14 days of static culture. However, by 21 days of culture the two indirectly
co-cultured iAC groups display more intense staining for cells and matrix within the scaffold
than the direct co-culture scaffold, dAC:MSC (Figure 3 and Supplementary Figure 2 (b)-
(d)). Among the dAC:MSC and iMSC groups in static culture, there was not a marked
difference in cell or matrix distribution at 21 days of culture even though there was a
somewhat more intense staining for collagen within the dAC:MSC scaffolds at 14 days. At
21 days of static culture, the iMSC 35 group displays greater amounts of collagenous matrix
within the scaffold than the MSC 35 or iMSC 17.5 groups (Figure 3 (e)-(g)). This difference
among the MSC groups, was not observed when examining cell localization (Supplementary
Figure 2 (e)-(g)).
Within the bioreactor cultures, staining for cells and ECM became more pronounced as the
culture duration increased from 5 to 14 days. Among the day 14 bioreactor scaffolds, the AC
35 and iAC 35 groups exhibited the greatest amount of staining for collagen both at the
surface of the scaffolds as well as in the interior (Figure 4 (a) and (b)). For all 3 time points,
the chondrocyte containing groups had greater amounts of collagen deposition than the
MSC-only samples. Among direct and indirectly co-cultured scaffolds, there was an
increased staining for collagen within the iAC 35 scaffolds compared to the directly co-
cultured dAC:MSC scaffolds at day 14 (Figure 4 (b) and (d)). Although, the direct co-
culture scaffolds showed greater collagen deposition at the first two time points compared to
the indirectly co-cultured MSC scaffolds, iMSC 35 and iMSC 17.5 (Figure 4 (d), (f) and
(g)). In general, the staining for cell localization showed very minor differences amongst the
bioreactor groups especially at the latest time point. All of the scaffolds displayed a dense
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coating of cells at the surface of the scaffolds at day 14. There were more cells located
inside the 3 groups seeded with chondrocytes alone than inside the 3 MSC-only groups
(Supplementary Figure 3 d14). The differences in cell localization were more pronounced at
the earlier time points where the 4 chondrocyte containing groups exhibited more intense
Nuclear Fast Red staining than the 3 MSC-only groups.
3.3. Biochemical characterization-Static
Cellularity, as determined by DNA content, increased gradually throughout the culture
period for the four static chondrocyte containing groups (Figure 5a “x” and “*”). In contrast,
when cultured statically little proliferation was observed within the three MSC-only groups.
Within the d21 static samples, iAC 17.5 displayed greater DNA contents than the dAC:MSC
group despite initially being seeded with fewer cells (Figure 5a “#”).
As with cell proliferation, the deposition of GAGs within the four chondrocyte containing
groups gradually increased with greater culture duration (Figure 6a “x” and “*”). The iAC
17.5 scaffolds were the only group to display a significant increase in GAG content between
d14 and d21 in addition to producing significantly greater GAG contents than the direct co-
culture group, dAC:MSC. Furthermore, the indirect co-culture AC scaffolds generated
significantly greater amounts of GAGs at d21 than the similarly cultured MSC scaffolds
(Figure 6a “‡”). When GAG content was normalized to the DNA content of the scaffolds,
there was no significant difference in GAG synthetic capacity observed among the statically
cultured scaffolds except for the d21 MSC 35 group which was found to be significantly
greater than the day 0 scaffolds (Figure 6b “x”).
Similar trends were observed in collagen production within the statically cultured groups as
were detected in scaffold cellularity and GAG content. Specifically, at d21 the indirectly co-
cultured chondrocyte group iAC 17.5 produced significantly greater amounts of collagen
than the direct co-culture group, dAC:MSC (Figure 7a “‡”). Furthermore, the chondrocyte
containing groups produced more collagen at d21 than the corresponding MSC containing
groups cultured similarly. However, there was little difference in collagen synthetic capacity
as determined by collagen content normalized to DNA content among the different
experimental groups (Figure 7b).
3.4. Biochemical characterization-Bioreactor
As in static cultures, cellularity increased gradually throughout the culture period for the
four chondrocyte containing groups cultured in the bioreactor (Figure 5b “x” and “*”). After
14 days of bioreactor culture, the two indirect co-culture chondrocyte scaffolds and the AC
35 samples exhibited significantly higher cell contents than the direct co-culture group,
dAC:MSC (Figure 5b “#”). Additionally, there was little proliferation observed within the
three MSC-only groups throughout the 14 days of bioreactor culture.
At day 14, the chondrocyte-only group and both indirect co-culture groups produced more
GAGs than the direct co-culture group, dAC:MSC (Figure 6c “#”), while no groups
contained more GAGs than the dAC:MSC groups at previous time points under flow
conditions. The AC scaffolds initially seeded with 35,000 chondrocytes, AC 35 and iAC 35,
generated significantly greater amounts of GAGs at d14 than the similarly cultured MSC
scaffolds (Figure 6c “‡”). Conversely, there was no significant difference in the GAG
content of iAC 17.5 and iMSC 17.5 groups after 14 days of bioreactor culture. There was an
increase in the deposition of GAGs as culture duration increased for the four chondrocyte
containing groups (Figure 6c “x” and “*”) with all of the groups containing significantly
greater GAG contents than their day 0 counterparts within 10 days of culture except for the
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iAC 35 samples. Conversely, as in static cultures, there were minimal changes in the
deposition of GAGs with time by the 3 MSC-only groups in the bioreactor.
While GAG synthetic capacity remained relatively stable in static culture, there were some
changes observed within the bioreactor cultures. An increase in GAG synthetic capacity was
observed at day 14 within the groups AC 35, iAC 35, and the two indirectly co-cultured
MSC groups, iMSC 35 and iMSC 17.5 (Figure 6d “x”). iMSC 17.5 was the only group at an
earlier time point to show a significant increase in GAG synthetic capacity.
Samples produced GAGs at a faster rate within the bioreactor than in static cultures as
qualitatively determined by the number of day 14 experimental groups to contain
significantly greater GAG contents than at initial time points. Specifically, after 14 days of
culture under flow conditions 5 groups had significantly greater GAG quantities than day 0
counterparts while none of the static groups were determined to be significantly greater than
day 0 in static cultures (Figures 6a and 6c “x”). In general, there were no significant
differences observed as the result of initial seeding density within the AC or MSC scaffolds
cultured via indirect co-culture in both static and flow conditions. The only exception
occurred in bioreactor GAG synthetic capacity at days 5 and 14 between groups iMSC 35
and iMSC 17.5 where iMSC 17.5 displayed a higher capacity for ECM synthesis (Figure
6d).
Scaffolds under flow conditions generated significant increases in collagen contents by 14
days of culture (Figure 7c “x” and “*”). All of the chondrocyte containing groups showed a
significant increase in collagen content over day 0 counterparts except for the direct co-
culture group, dAC:MSC. Moreover, both groups seeded initially with 35,000 chondrocytes/
scaffold, AC 35 and iAC 35, generated significantly greater amounts of collagen than the
dAC:MSC group after 14 days of bioreactor culture. Additionally, the AC 35 group,
consisting of chondrocytes cultured on PCL alone without any form of co-culture, produced
more collagen within the PCL scaffold than all three chondrocyte containing co-culture
groups (Figure 7c “#” and “+”). As with previous results examining matrix production, there
was little difference between the three MSC cultured groups in the bioreactor
There was a rather marked increase in collagen synthetic capacity within the bioreactor
groups between days 10 and 14 (Figure 7d “x” and “*”). This is somewhat different from the
gradual or nonexistent changes in ECM synthetic activity that were observed in static
cultures as well as bioreactor GAG synthetic capacity.
4. Discussion
This study demonstrated the influence of direct and indirect co-culture of chondrocytes and
MSCs on the development of cartilage-like ECM, as defined by an increase in GAG and
collagen deposition, within a fibrous PCL scaffold under static and perfused culture
conditions. Specifically, the results suggest that polymer/ECM hybrid scaffolds containing
GAGs and collagen may be generated by utilizing the factors secreted by two different cell
types, chondrocytes and MSCs, even in the absence of direct cell-cell contact. This was
demonstrated in both static and perfused cultures. Utilizing cell culture to generate ECM
coatings on polymeric scaffolds is a relatively novel approach to producing natural/synthetic
hybrid scaffolds. Other methods of fabricating similar hybrid scaffold materials by coating
3D polymer scaffolds with isolated ECM components, such as collagen or GAGs, benefit
from well characterized and controlled formulations [8, 12, 13, 37, 38]. However, using cell
culture to generate polymer/ECM hybrid scaffolds has the potential to deposit ECM
components in physiologically active conformations as well as potentially incorporate
growth factors and other morphogens useful for directing tissue regeneration [14, 34, 39].
Levorson et al. Page 8













By studying in vitro cell generated polymer/ECM hybrid scaffolds using a variety of cell
sources, we have shown previously that flow perfusion, oxygen tension, as well as culture
supplements can be useful for the generation of scaffolds for both bone and cartilage
regeneration [30, 31, 34, 40-42]. Furthermore, it has been demonstrated that upon
devitalization these various polymer/ECM hybrid scaffolds are capable of inducing the
osteogenic and chondrogenic differentiation of MSCs [14, 28, 34, 35, 40, 42]. Recent studies
have focused on utilizing co-cultures of chondrocytes and MSCs to generate cartilage-like
ECM within a scaffold capable of directing cartilage regeneration. In these studies, results
indicated that in direct co-cultures of chondrocytes and MSCs there is a stimulatory effect
on the production of cartilage-like ECM [15, 16]. Specifically, co-cultures of chondrocytes
and MSCs in equal proportions generated constructs with similar quantities and spatial
distributions of cartilage-like ECM as constructs produced by chondrocytes alone [15].
Furthermore, as compared to untreated PCL controls, devitalized PCL/ECM scaffolds
generated by culturing with a 1:1 chondrocyte to MSC ratio had a positive effect on the
aggrecan and collagen type II gene expression of MSCs [28]. This echoes previous results
which indicated that PCL/ECM generated by chondrocytes in a flow perfusion bioreactor
led to a decrease in collagen type I expression of reseeded MSCs and an increase in the
capacity for the MSCs to produce cartilage-like ECM [14]. The work described here
functioned to further investigate the fabrication of these co-culture generated
chondroinductive PCL/ECM constructs by determining the benefit of direct versus indirect
co-culture in the capacity to form significant amounts of GAGs and collagen distributed
throughout the scaffold. Specifically, we hypothesized that direct cell-cell contact as well as
cell-secreted trophic factors may influence ECM production within the fibrous scaffolds.
In static cultures, no difference in cellularity or ECM content was determined between the
chondrocyte-only group seeded with 35,000 chondrocytes, AC 35, and the indirect co-
culture group, iAC 17.5, that was seeded with half as many chondrocytes initially.
Conversely, the indirectly co-cultured group iAC 17.5 led to significant increases in
cellularity and ECM content over the direct co-culture samples, dAC:MSC, in 21 days of
static culture even though it was seeded with the same number of chondrocytes initially
(Figures 5a, 6a, and 7a “#”). Upon examining ECM synthetic capacity within the
chondrocyte containing groups, there was very little difference among the various
experimental groups. As such, it follows that in static cultures the ultimate production of
ECM within the PCL scaffolds was highly dependent on the total number of cells present to
secrete matrix throughout the culture duration. Furthermore, it appears as though the
cellularity at the later time point was not dependent on the initial seeding density as the
groups seeded with half the amount of cells initially, iAC 17.5 and iMSC 17.5, ultimately
attained similar DNA contents as the other groups seeded with similar cell types but at twice
the initial seeding density. One potential explanation for this behavior is that within these
fibrous scaffolds cells may proliferate to the point of overcrowding within 21 days of static
culture possibly inducing a contact inhibition-like response [43, 44].
SEM of scaffolds cultured statically for 14 and 21 days shows the surface is covered and
appears similar for chondrocyte seeded scaffolds cultured statically (Supplementary Figure
1). Based on histology, there is a large amount of cells and ECM at the surface of the
scaffolds as told by SEM. However differences among the groups lie within the interior of
the scaffolds where the scaffolds seeded solely with chondrocytes, AC 35, iAC 35, and
iAC17.5, show thorough distributions of cells and matrix within the scaffolds when
dAC:MSC and MSC scaffolds are somewhat sparse in comparison (Figure 3 and
Supplementary Figure 2). When compared to the DNA and ECM contents of the scaffolds, it
follows that more thorough distributions of cells and ECM throughout the structure would
be correlated to higher quantities of DNA and ECM within the scaffold. This interplay
between cellular distribution within a scaffold and its influence on proliferation and tissue
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development is oftentimes investigated under flow perfusion which has shown to lead to
improved cellular distributions over static culture [44-46].
In an earlier co-culture study conducted in serum-free media with TGF-β3 supplementation,
it was found that while MSCs gradually decrease in proportion throughout the culture period
the co-cultures composed of as much as 75% MSCs initially led to increases in GAG content
and improved collagen type II expression over chondrocyte cultures [16]. Additionally,
based on rtPCR using species specific primers it was determined that within these direct co-
cultures the majority of the chondrogenic expression originated from the chondrocytes;
suggesting that the MSCs had a stimulatory effect on the chondrocytes [16]. For purpose of
our investigation, flow perfusion bioreactor culture was utilized to not only improve general
gas and nutrient transport properties [33, 46, 47], but also to flush any factors secreted by the
MSCs through the chondrocyte containing scaffolds in order to further examine the potential
response due to paracrine signaling within indirect co-cultures. Moving from static to
perfused culture, shorter culture durations were necessary in the bioreactor as extended
periods of perfusion culture oftentimes fail due to cell proliferation and matrix deposition
blocking the media flow path. Alternately, in order to observe significant differences in
static culture longer culture durations were needed. In addition, as different media volumes
were necessary for the two different culture conditions, statistical analyses comparing the
proliferation and matrix production in static versus bioreactor culture were not performed.
As in static culture, the cartilage-like ECM synthetic capacities of the three chondrocyte
containing co-culture groups showed no statistically significant differences under flow
conditions (Figures 6d and 7d). However, unlike in static culture the two indirect co-culture
groups, iAC 35 and iAC 17.5, resulted in significant increases in cellularity by day 14 over
the direct co-culture group with iAC 35 also showing a significant increase in ECM content
over the direct co-culture group. As the direct co-cultures did not surpass the matrix
production by the indirect co-cultures, it may possible to generate PCL/ECM hybrid
scaffolds for cartilage regeneration by utilizing the factors secreted by two different cell
types, chondrocytes and MSCs, without juxtacrine signaling. Although decellularized PCL/
ECM hybrid scaffolds generated similarly have shown chondrogenic effects on reseeded
MSCs in the form of increased aggrecan and collagen type II expression [28], to further
understand the interplay between these two cell types and the influence on ECM production
the specific composition of the ECM must be investigated further in future studies.
A previous study performed by Bian et al, showed that mixed populations of MSCs and
chondrocytes encapsulated in hydrogels resulted in improved matrix production compared to
MSC and chondrocyte-only controls. However, there was no benefit of indirect co-cultures
of MSC-only encapsulated hydrogels cultured together with chondrocyte-only encapsulated
hydrogels [21]. It may be possible that hydrogel encapsulation could constrain the diffusion
of secreted factors and cellular infiltration [48]. As such, this work investigated the influence
of direct and indirect co-culture on matrix production in a fibrous mesh scaffold as well as
with perfused flow in an effort to improve the dispersion of secreted signals. This study also
utilized a previously validated xenogeneic co-culture model [15, 16, 30]. In this model,
rabbit MSCs were employed in keeping with the regularly used rabbit in vivo model for
cartilage engineering [49-52] and bovine chondrocytes were utilized to reduce the number of
animals needed due to the limited tissue available for chondrocyte isolation from rabbit
condyles. The development of a xenogeneic co-culture model has shown to be not only
useful in elucidating some of the positive effects of allogeneic co-culture, but also enables
the potential to perform species specific characterization methodologies [16, 22, 24].
Within 14 days of culture under perfused flow all of the experimental groups exhibited
approximately similar DNA contents as those observed in equal or greater durations of static
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culture. Furthermore, bioreactor culture led to faster proliferation rates within the
chondrocyte containing groups than static culture with significant changes observed at 5 and
10 days as opposed to 21 days in static (Figure 5 “x”). Similar results were observed
previously, in that perfusion led to improved proliferation and GAG deposition by
chondrocytes over static cultures [31]. While fluid flow had a significant influence on
cellular proliferation in the chondrocyte containing groups, there was no significant change
in the DNA content of the three MSC-only scaffolds regardless of co-culture. These results
suggest that perfusion has more of an influence on chondrocyte proliferation than MSC
growth regardless of co-culture. Additionally, the presence of MSCs in indirect co-culture
did not appear to have a negative effect on chondrocyte growth which was a potential
concern as nutrient limitations have shown to impose growth inhibition [43].
While little proliferation or increase in ECM content was observed within the three MSC-
only scaffolds in both static and perfused culture, for both iMSC groups the GAG synthetic
capacity was higher than their iAC counterparts in the bioreactor (Figure 6d “‡”). There was
also a temporal increase in ECM synthetic capacity observed within the MSC indirect co-
culture scaffolds, iMSC 35 and iMSC 17.5, while no change was observed within the MSC-
only scaffolds, MSC 35 (Figures 6d and 7d). It is important to note that within the bioreactor
design employed here, the indirect MSC scaffolds were not directly perfused with media
rather the scaffolds were cultured loosely within the media that would then flow through the
chondrocyte containing scaffolds. As no change in ECM anabolic capacity was observed in
static cultures or the media perfused MSC-only scaffolds, it follows that cellular secreted
factors from indirect co-culture resulted in improvement in the ECM production by MSCs.
Additionally, qualitatively indirect co-culture paired with bioreactor culture resulted in
improved cellular localization and ECM distribution throughout the MSC-only scaffolds
over static culture (Figures 3-4 and Supplementary Figures 2-3 d14 (e)-(g)). As previous
reports have focused on the effect of MSCs on matrix production by chondrocytes this
alteration in MSC ECM synthetic capacity within indirect co-cultures was unexpected [16,
24, 53]. Future work is needed to more thoroughly investigate the influence of direct and
indirect co-culture on the differentiation state of MSCs. It is possible that direct co-culture
has masked some of the subtle positive effects co-culture with chondrocytes has on MSCs.
Various studies have indicated that MSCs secrete trophic factors including IGF-1, TGF-β,
and BMP-2 which are known to have a positive effect on the chondrocytic phenotype [25,
54-56]. Conversely, this and other studies have shown that chondrocytes also influence the
chondrogenic differentiation of MSCs, as evidenced by improved ECM synthetic capacity,
through the secretion of paracrine factors such as parathyroid hormone–related protein [20,
25, 27, 57, 58]. In some cases, when cultured in separated co-culture with chondrocytes via
Transwell® plates or treated with chondrocyte conditioned media MSCs have shown
improved chondrogenesis and reduced hypertrophy [17, 19, 20, 57]. From these various
results, it appears that the relationship within chondrocyte and MSC co-cultures is complex
and continued mechanistic work needs to be carried out in an effort to fully understand the
communication occurring between these two cell types in an effort to improve tissue
regeneration.
5. Conclusions
The objective of this study was to examine the influence of direct cell-cell contact in co-
cultures of MSCs and chondrocytes on the deposition of cartilage-like ECM within
nonwoven fibrous PCL scaffolds. In static culture, the indirectly co-cultured chondrocytes
with the lower seeding density led to significant increases in cellularity and ECM content
over the direct co-cultures of chondrocytes and MSCs despite being seeded with the same
number of chondrocytes initially. Within static cultures, the ultimate production of ECM
within the PCL scaffolds was highly dependent on the number of cells present to secrete
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matrix and their distribution in the scaffold. However, ECM production was not contingent
on the initial number of cells seeded. Perfused culture has previously shown to result in
improved distributions in 3D scaffolds, and was utilized here to examine the interplay
between direct and indirect co-culture in another manner. Fluid flow had more of a
significant effect on the proliferation of chondrocytes than on MSCs. Additionally, within
bioreactor culture there were indications that chondrocytes had an influence on the
chondrogenesis of MSCs as evidenced by increases in cartilaginous ECM synthetic capacity.
These results indicate that polymer/ECM hybrid scaffolds may be formed by utilizing the
factors secreted by two different cell types, chondrocytes and MSCs, even in the absence of
direct cell-cell contact.
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(a) Schematic indicating seeding and culture arrangement for experimental groups. Divided
rectangles are used to represent polypropylene mesh divided wells for static culture. Similar
pairings were used in bioreactor culture with scaffolds on the left confined in perfusion
cassettes and scaffolds on the right or blank PCL scaffolds included above the cassette as
free scaffolds. (b) Bioreactor schematic with free and perfused scaffolds allowing for
indirect co-culture under flow conditions.
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SEM images depicting the surface morphology of samples cultured in the bioreactor for 5,
10, and 14 days. (a) AC 35, (b) iAC 35, (c) iAC 17.5, (d) dAC:MSC, (e) MSC 35, (f) iMSC
35, (g) iMSC 17.5. Scale bars represent 50 μm. Magnification 1000x for all images.
Levorson et al. Page 17














Histological sections of static samples stained with Picro Sirius Red. Red staining depicts
localization of collagen deposits in scaffolds after 14 and 21 days of static culture. (a) AC
35, (b) iAC 35, (c) iAC 17.5, (d) dAC:MSC, (e) MSC 35, (f) iMSC 35, (g) iMSC 17.5. Scale
bars represent 100 μm. Magnification 1000x for all images.
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Histological sections of bioreactor samples stained with Picro Sirius Red. Red staining
depicts localization of collagen deposits in scaffolds after 5, 10, and 14 days of bioreactor
culture. (a) AC 35, (b) iAC 35, (c) iAC 17.5, (d) dAC:MSC, (e) MSC 35, (f) iMSC 35, (g)
iMSC 17.5. Scale bars represent 100 μm. Magnification 1000x for all images.
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DNA content for (a) statically and (b) flow perfusion cultured scaffolds at each time point.
Symbols indicating statistical significance are defined in Table 2. p<0.05.
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Characterization of GAG production in static cultures. Total GAG content for (a) statically
and (c) flow perfusion cultured scaffolds at each time point. Glycosaminoglycan synthetic
activity as normalized to DNA content (b) statically and (d) flow perfusion cultured
scaffolds. Symbols indicating statistical significance are defined in Table 2. p<0.05.
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Characterization of collagen production in static cultures. Total collagen content for (a)
statically and (c) flow perfusion cultured scaffolds at each time point. Collagen synthetic
activity as normalized to DNA content (b) statically and (d) flow perfusion cultured
scaffolds. Symbols indicating statistical significance are defined in Table 2. p<0.05.
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Table 1
Description of experimental groups with cell types and densities seeded.
Experimental Group Chondrocytes/scaffold MSCs/scaffold
AC 35 35,000 -
MSC 35 - 35,000
dAC:MSC 17,500 17,500
iAC 35 35,000 -
iMSC 35 - 35,000
iAC 17.5 17,500 -
iMSC 17.5 - 17,500
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Table 2
Definition of symbols representing statistical significance. p < 0.05.
Symbol Meaning
# Statistically significant difference from dAC:MSC group.
+ Statistically significant difference between an indirectly co-cultured group and chondrocyte-alone (AC 35) or MSC-alone (MSC 35)
group of the same cell type.
‡ Difference between AC and MSC groups cultured similarly. Significance is indicated above the MSC containing counterpart only.
× Statistically significant difference from the corresponding initial time point.
* Statistically significant difference from the directly preceding time point.
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